Incyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
CEOWilliam J. Meury
CEOWilliam J. Meury
Employees2,617
Employees2,617
HeadquartersWilmington, Delaware
HeadquartersWilmington, Delaware
Founded1991
Founded1991
Employees2,617
Employees2,617
INCY Key Statistics
Market cap16.90B
Market cap16.90B
Price-Earnings ratio19.70
Price-Earnings ratio19.70
Dividend yield—
Dividend yield—
Average volume1.71M
Average volume1.71M
High today$88.88
High today$88.88
Low today$85.18
Low today$85.18
Open price$86.50
Open price$86.50
Volume1.16M
Volume1.16M
52 Week high$88.88
52 Week high$88.88
52 Week low$53.56
52 Week low$53.56
INCY News
TipRanks 4d
Incyte price target raised to $104 from $90 at BofABofA analyst Tazeen Ahmad raised the firm’s price target on Incyte (INCY) to $104 from $90 and keeps a Buy rating on the shares. After having hosted the company...
Analyst ratings
52%
of 27 ratingsBuy
37%
Hold
51.9%
Sell
11.1%
People also own
Based on the portfolios of people who own INCY. This list is generated using Robinhood data, and it’s not a recommendation.